BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 25133494)

  • 1. Fine-tuning of Smad protein function by poly(ADP-ribose) polymerases and poly(ADP-ribose) glycohydrolase during transforming growth factor β signaling.
    Dahl M; Maturi V; Lönn P; Papoutsoglou P; Zieba A; Vanlandewijck M; van der Heide LP; Watanabe Y; Söderberg O; Hottiger MO; Heldin CH; Moustakas A
    PLoS One; 2014; 9(8):e103651. PubMed ID: 25133494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global analysis of transcriptional regulation by poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase in MCF-7 human breast cancer cells.
    Frizzell KM; Gamble MJ; Berrocal JG; Zhang T; Krishnakumar R; Cen Y; Sauve AA; Kraus WL
    J Biol Chem; 2009 Dec; 284(49):33926-38. PubMed ID: 19812418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic activity of poly (ADP-ribose) glycohydrolase.
    Marques M; Jangal M; Wang LC; Kazanets A; da Silva SD; Zhao T; Lovato A; Yu H; Jie S; Del Rincon S; Mackey J; Damaraju S; Alaoui-Jamali M; Witcher M
    Oncogene; 2019 Mar; 38(12):2177-2191. PubMed ID: 30459355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Bone Morphogenetic Protein Signaling by ADP-ribosylation.
    Watanabe Y; Papoutsoglou P; Maturi V; Tsubakihara Y; Hottiger MO; Heldin CH; Moustakas A
    J Biol Chem; 2016 Jun; 291(24):12706-12723. PubMed ID: 27129221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatial and functional relationship between poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase in the brain.
    Poitras MF; Koh DW; Yu SW; Andrabi SA; Mandir AS; Poirier GG; Dawson VL; Dawson TM
    Neuroscience; 2007 Aug; 148(1):198-211. PubMed ID: 17640816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(ADP-ribose) polymerase-1 regulates fibroblast activation in systemic sclerosis.
    Zhang Y; Pötter S; Chen CW; Liang R; Gelse K; Ludolph I; Horch RE; Distler O; Schett G; Distler JHW; Dees C
    Ann Rheum Dis; 2018 May; 77(5):744-751. PubMed ID: 29431122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective down-regulation of nuclear poly(ADP-ribose) glycohydrolase.
    Burns DM; Ying W; Kauppinen TM; Zhu K; Swanson RA
    PLoS One; 2009; 4(3):e4896. PubMed ID: 19319190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of the nuclear isoform of poly(ADP-ribose) glycohydrolase (PARG) reveals its function in DNA repair, genomic stability and tumorigenesis.
    Min W; Cortes U; Herceg Z; Tong WM; Wang ZQ
    Carcinogenesis; 2010 Dec; 31(12):2058-65. PubMed ID: 20926829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(ADP-ribose) polymerase 1 is indispensable for transforming growth factor-β Induced Smad3 activation in vascular smooth muscle cell.
    Huang D; Wang Y; Wang L; Zhang F; Deng S; Wang R; Zhang Y; Huang K
    PLoS One; 2011; 6(10):e27123. PubMed ID: 22073128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PARP-1 attenuates Smad-mediated transcription.
    Lönn P; van der Heide LP; Dahl M; Hellman U; Heldin CH; Moustakas A
    Mol Cell; 2010 Nov; 40(4):521-32. PubMed ID: 21095583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered poly(ADP-ribose) metabolism impairs cellular responses to genotoxic stress in a hypomorphic mutant of poly(ADP-ribose) glycohydrolase.
    Gao H; Coyle DL; Meyer-Ficca ML; Meyer RG; Jacobson EL; Wang ZQ; Jacobson MK
    Exp Cell Res; 2007 Mar; 313(5):984-96. PubMed ID: 17276427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of poly(ADP-ribose) polymerase-1 or poly(ADP‑ribose) glycohydrolase individually, but not in combination, leads to improved chemotherapeutic efficacy in HeLa cells.
    Feng X; Koh DW
    Int J Oncol; 2013 Feb; 42(2):749-56. PubMed ID: 23254695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective targeting of activating and inhibitory Smads by distinct WWP2 ubiquitin ligase isoforms differentially modulates TGFβ signalling and EMT.
    Soond SM; Chantry A
    Oncogene; 2011 May; 30(21):2451-62. PubMed ID: 21258410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PARG Inhibitors and Functional PARG Inhibition Models.
    Sasaki Y; Hozumi M; Fujimori H; Murakami Y; Koizumi F; Inoue K; Masutani M
    Curr Protein Pept Sci; 2016; 17(7):641-653. PubMed ID: 27817742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mediation of cell death by poly(ADP-ribose) polymerase-1.
    Koh DW; Dawson TM; Dawson VL
    Pharmacol Res; 2005 Jul; 52(1):5-14. PubMed ID: 15911329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drosophila poly(ADP-ribose) glycohydrolase mediates chromatin structure and SIR2-dependent silencing.
    Tulin A; Naumova NM; Menon AK; Spradling AC
    Genetics; 2006 Jan; 172(1):363-71. PubMed ID: 16219773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic investigation of phosphorylation sites in poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase.
    Gagné JP; Moreel X; Gagné P; Labelle Y; Droit A; Chevalier-Paré M; Bourassa S; McDonald D; Hendzel MJ; Prigent C; Poirier GG
    J Proteome Res; 2009 Feb; 8(2):1014-29. PubMed ID: 19105632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(ADP-ribose): PARadigms and PARadoxes.
    Bürkle A; Virág L
    Mol Aspects Med; 2013 Dec; 34(6):1046-65. PubMed ID: 23290998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Poly (ADP-Ribose) Glycohydrolase Accelerates Osteoblast Differentiation in Preosteoblastic MC3T3-E1 Cells.
    Sasaki Y; Nakatsuka R; Inouchi T; Masutani M; Nozaki T
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A quantitative assay reveals ligand specificity of the DNA scaffold repair protein XRCC1 and efficient disassembly of complexes of XRCC1 and the poly(ADP-ribose) polymerase 1 by poly(ADP-ribose) glycohydrolase.
    Kim IK; Stegeman RA; Brosey CA; Ellenberger T
    J Biol Chem; 2015 Feb; 290(6):3775-83. PubMed ID: 25477519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.